Source: Journal of Cancer Research and Clinical Oncology. Unidade: ICB
Subjects: IMUNOLOGIA, CAMUNDONGOS, MODELOS ANIMAIS DE DOENÇAS, CÉLULAS CULTIVADAS DE TUMOR, VARIAÇÃO GENÉTICA, COMPLEXOS MULTIENZIMÁTICOS, NUCLEOTÍDEOS, NEOPLASIAS DO COLON, ESTUDOS DE COORTES, GENÓTIPOS
ABNT
CAMBUI, Raylane Adrielle Gonçalves et al. The Ala134Thr variant in TMEM176B exerts a beneficial role in colorectal cancer prognosis by increasing NLRP3 inflammasome activation. Journal of Cancer Research and Clinical Oncology, p. 1-10, 2022Tradução . . Disponível em: https://doi.org/10.1007/s00432-022-04284-8. Acesso em: 28 ago. 2024.APA
Cambui, R. A. G., Fernandes, F. P., Leal, V. N. C., Reis, E. C. dos, Lima, D. S. de, Santo, G. F. do E., et al. (2022). The Ala134Thr variant in TMEM176B exerts a beneficial role in colorectal cancer prognosis by increasing NLRP3 inflammasome activation. Journal of Cancer Research and Clinical Oncology, 1-10. doi:10.1007/s00432-022-04284-8NLM
Cambui RAG, Fernandes FP, Leal VNC, Reis EC dos, Lima DS de, Santo GF do E, Elias RM, Pontillo A. The Ala134Thr variant in TMEM176B exerts a beneficial role in colorectal cancer prognosis by increasing NLRP3 inflammasome activation [Internet]. Journal of Cancer Research and Clinical Oncology. 2022 ; 1-10.[citado 2024 ago. 28 ] Available from: https://doi.org/10.1007/s00432-022-04284-8Vancouver
Cambui RAG, Fernandes FP, Leal VNC, Reis EC dos, Lima DS de, Santo GF do E, Elias RM, Pontillo A. The Ala134Thr variant in TMEM176B exerts a beneficial role in colorectal cancer prognosis by increasing NLRP3 inflammasome activation [Internet]. Journal of Cancer Research and Clinical Oncology. 2022 ; 1-10.[citado 2024 ago. 28 ] Available from: https://doi.org/10.1007/s00432-022-04284-8